Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chris Runken

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Health Care Finance|January 29, 2009
Chronic disease prevalence and burden in elderly men: an analysis of Medicare medical claims dataLibby Black, M Chris Runken, Michael Eaddy, et al.
The American Journal of Managed Care|February 14, 2007
Finasteride versus dutasteride: a real-world economic evaluationThomas C Fenter, M Chris Runken, Libby Black, et al.
The American Journal of Managed Care|February 14, 2007
A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasterideMuta M Issa, M Chris Runken, Amy L Grogg, et al.
Mayo Clinic Proceedings|May 5, 2009
The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future researchWayne N Burton, Stephen H Landy, Kristen E Downs, et al.
Health Economics Review|July 7, 2019
The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and SpainM Chris Runken, Paolo Caraceni, Javier Fernandez, et al.
Health Economics Review|April 19, 2020
Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and SpainM Chris Runken, Paolo Caraceni, Javier Fernandez, et al.
American Health & Drug Benefits|July 27, 2019
Treatment Patterns and Costs of Chronic Inflammatory Demyelinating Polyneuropathy: A Claims Database AnalysisJeffrey T Guptill, M Chris Runken, Michael Eaddy, et al.
Headache|October 10, 2013
Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan/naproxen sodium combinationStephen H Landy, Roger K Cady, Andrew Nelsen, et al.
Frontiers in Immunology|August 22, 2025
The impact of intravenous immunoglobulin therapy on resource utilization associated with viral respiratory tract infectionsAntoine Azar, M Chris Runken, Eric Moughames, et al.
Journal of the Neurological Sciences|November 26, 2019
Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?Jeffrey A Allen, Deborah F Gelinas, Miriam Freimer, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Health Care Finance|January 29, 2009
Chronic disease prevalence and burden in elderly men: an analysis of Medicare medical claims dataLibby Black, M Chris Runken, Michael Eaddy, et al.
The American Journal of Managed Care|February 14, 2007
Finasteride versus dutasteride: a real-world economic evaluationThomas C Fenter, M Chris Runken, Libby Black, et al.
The American Journal of Managed Care|February 14, 2007
A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasterideMuta M Issa, M Chris Runken, Amy L Grogg, et al.
Mayo Clinic Proceedings|May 5, 2009
The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future researchWayne N Burton, Stephen H Landy, Kristen E Downs, et al.
Health Economics Review|July 7, 2019
The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and SpainM Chris Runken, Paolo Caraceni, Javier Fernandez, et al.
Health Economics Review|April 19, 2020
Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and SpainM Chris Runken, Paolo Caraceni, Javier Fernandez, et al.
American Health & Drug Benefits|July 27, 2019
Treatment Patterns and Costs of Chronic Inflammatory Demyelinating Polyneuropathy: A Claims Database AnalysisJeffrey T Guptill, M Chris Runken, Michael Eaddy, et al.
Headache|October 10, 2013
Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan/naproxen sodium combinationStephen H Landy, Roger K Cady, Andrew Nelsen, et al.
Frontiers in Immunology|August 22, 2025
The impact of intravenous immunoglobulin therapy on resource utilization associated with viral respiratory tract infectionsAntoine Azar, M Chris Runken, Eric Moughames, et al.
Journal of the Neurological Sciences|November 26, 2019
Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?Jeffrey A Allen, Deborah F Gelinas, Miriam Freimer, et al.
Pageof 4